DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Torsemide (Torsemide) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Torsemide side effects in female

Reported by a physician from United States on 2012-07-02

Patient: female, weighing 180.0 kg (396.0 pounds)

Reactions: Diarrhoea, Anaphylactic Shock, Dermatitis Exfoliative

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ibuprofen
    Dosage: 2400 milligram;
    Administration route: Oral
    Start date: 2011-06-01

Rosuvastatin
    Dosage: 20 milligram;
    Administration route: Oral
    Start date: 2011-06-01

Savella
    Dosage: 50 milligram;
    Administration route: Oral
    Start date: 2011-09-10
    End date: 2011-09-12

Omeprazole
    Dosage: 20 milligram;
    Administration route: Oral

Savella
    Dosage: 12.5 milligram;
    Administration route: Oral
    Indication: Fibromyalgia
    Start date: 2011-09-07
    End date: 2011-09-07

Lovaza
    Administration route: Oral
    Start date: 2011-09-07

Torsemide
    Dosage: 80 milligram;
    Administration route: Oral
    Start date: 2011-07-13

Other drugs received by patient: Metformin Hydrochloride; Potassium; Amoxicillin; Cinnamon; Vaccinium Macrocarpon; Bupropion HCL; Lisinopril; M.v.i.; Warfarin Sodium; Allopurinol; Amitriptyline HCL; Glimepiride; Propranolol; Fenofibrate; Oxybutynin; Colecalciferol; Vicodin; Phentermine Hydrochloride; Levothyroxine Sodium



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Carmen
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-29

Patient: 87 year old female

Reactions: Vascular Insufficiency, Drug Ineffective, Oedema, Condition Aggravated, LEG Amputation, Hypertension

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 mg), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Other drugs received by patient: Alprostadil; Pletal; Dorner (Beraprostsodium)



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-29

Patient: 87 year old female

Reactions: Poor Peripheral Circulation, LEG Amputation

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Sarpogrelate
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Alprostadil; Dorner; Pletal



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-19

Patient: 87 year old female

Reactions: Poor Peripheral Circulation, LEG Amputation

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Sarpogrelate
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension

Torsemide
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Other drugs received by patient: Dorner; Pletal; Alprostadil



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-13

Patient: 87 year old female

Reactions: Intermittent Claudication, Pain, Oedema, Hypoaesthesia, LEG Amputation, Gait Disturbance, Feeling Cold

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 m), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Pletal; Dorner (Beraprost Sodium); Paulux (Alprostadil)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017